جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

2 مُخرَج نتائج البحث عن «Concomitant»

مقالوصول مغلق2026

Trends in Cardiomyopathy and Atrial Fibrillation-Related Mortality Among US Adults, 1999–2024

Population Health Management · مجلد 29 (4) · 233-241

Atrial fibrillation (AF) is a highly prevalent comorbidity in patients with cardiomyopathy (CM), associated with worse cardiovascular outcomes. This study aims to provide a comprehensive, national-level analysis of AF and CM-related mortality in the United States. The Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database was utilized, using death certificates from 1999 to 2024. The study included patients aged ≥15 years with CM and AF. Statistical analyses were conducted to calculate age-adjusted mortality rates (AAMRs) per 100,000 individuals and annual percent changes with 95% confidence intervals (CIs). Between 1999 and 2024, CM with concomitant AF accounted for 134,470 deaths among individuals aged 15 years or older. The overall AAMR rose from 1.5 per 100,000 in 1999 to 2.3 in 2024. From 1999 to 2016, the AAMR rose modestly (1.5-1.8), followed by a pronounced rise from 2016 to 2022 (1.8-2.5), and a relative decline by 2024 (2.5-2.3). Compared with 2019, mortality in 2020 demonstrated a 15% relative increase (incidence rate ratio = 1.15; 95% CI: 1.11-1.19). Males had disproportionately higher AAMRs compared to females. By race, the highest AAMRs were observed in non-Hispanic (NH) Black and White populations (1.8 each). Regionally, the West and Midwest exhibited the highest AAMRs (1.9 each). Urban-rural stratification revealed higher AAMRs among rural areas (2.2) when compared with urban (1.8) areas. Targeted public-health interventions and resource allocation to address this growing cardiovascular mortality burden, particularly in high-risk demographic groups, are needed.

cardiomyopathyatrial fibrillationmortality trendscomorbidities
مقالوصول مغلق2025

Trends in pulmonary embolism and atrial fibrillation-related mortality in adult US population: a CDC WONDER analysis from 1999 to 2020

European Heart Journal · مجلد 46 (Supplement_1)

Abstract Background Pulmonary embolism (PE) continues to be a major contributor to mortality in the United States. Among the various risk factors associated with this life-threatening condition, atrial fibrillation (AF) stands as a significant contributor, further complicating the health challenges faced by patients. Purpose This study aims to uncover critical trends and regional disparities in mortality related to PE with concomitant AF across the United States from 1999 to 2020. Methods Death certificate data from the Centers for Disease Control and Prevention Wide-Ranging OnLine Data for Epidemiologic Research (CDC WONDER) database was to evaluate mortality associated with pulmonary embolism (PE) and atrial fibrillation/flutter (AF) from 1999 to 2020 for adults >15 years. Age-adjusted mortality rates (AAMRs) per 100,000 individuals, and Annual Percent Change (APCs) along with their 95% confidence intervals (CIs) were also calculated. Data were stratified by year, sex, race, and census region. Results PE with comorbid AF in adults aged ≥ 15 years resulted in 38,848 deaths, with an overall AAMR 0.70 (APC - 4.45; 95% CI: 3.94 – 4.96). The AAMR increased from 0.4 in 1999 to 0.8 in 2018 (APC: 4.2; 95% CI: 3.6 to 4.8), and further increased to 1.1 in 2020 (APC: 11.97; 95% CI: -7.3 – 35.2). Similar AAMR values were reported in both male and female in 1999 (AAMR: 0.4), however, men showed a slightly higher increase by 2020 (AAMR men: 1.4 vs women: 1.0). Non-Hispanic (NH) White adults had the highest overall AAMR (0.7), followed by NH Black (0.6), NH American Indian/Alaska Native (0.4), Hispanic or Latino (0.3), and NH Asian or Pacific Islander adults (0.2). AAMR did not vary substantially by region (overall AAMR: Midwest 0.7; South: 0.7; West: 0.7; Northeast: 0.6), and metropolitan areas had higher PE with comorbid AF-related AAMR (1.0) than nonmetropolitan areas (0.8). Wyoming, Colorado, and Vermont ranked in the top 90th percentile for PE with comorbid AF-related AAMR, with rates nearly four times higher than states in the lowest 10th percentile. Conclusion There’s been a steady increase in PE mortality with comorbid AF over the last 20 years. AAMR values were greater among non-Hispanic Adults, and those residing in metropolitan areas of the US. Notably, a sharper rise in AAMR post-2018 has been reported in both males and females. These findings highlight the importance of addressing and developing targeted interventions to curb the increased PE with comorbid AF mortality rates in the vulnerable population.

pulmonary embolismatrial fibrillationatrial fluttermortality trends